| __timestamp | Insmed Incorporated | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56292000 | 241751000 |
| Thursday, January 1, 2015 | 74277000 | 322292000 |
| Friday, January 1, 2016 | 122721000 | 344320000 |
| Sunday, January 1, 2017 | 109749000 | 374644000 |
| Monday, January 1, 2018 | 145283000 | 414604000 |
| Tuesday, January 1, 2019 | 131711000 | 466000000 |
| Wednesday, January 1, 2020 | 181157000 | 535000000 |
| Friday, January 1, 2021 | 272744000 | 643000000 |
| Saturday, January 1, 2022 | 397518000 | 833000000 |
| Sunday, January 1, 2023 | 571011000 | 899625000 |
| Monday, January 1, 2024 | 901530000 |
Data in motion
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Insmed Incorporated and Ionis Pharmaceuticals, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical breakthroughs.
From 2014 to 2023, Insmed's R&D expenses surged by over 900%, starting from a modest $56 million to an impressive $571 million. This growth underscores Insmed's strategic focus on expanding its research capabilities and pipeline.
Ionis Pharmaceuticals, on the other hand, maintained a robust R&D budget, increasing its spending by approximately 270% over the same period. By 2023, Ionis's R&D expenses reached nearly $900 million, solidifying its position as a leader in the biotech sector.
These trends highlight the dynamic nature of the biotech industry, where sustained investment in R&D is crucial for long-term success.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Insmed Incorporated
Cost of Revenue: Key Insights for Insmed Incorporated and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Grifols, S.A.
Insmed Incorporated or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Research and Development Expenses Breakdown: Insmed Incorporated vs Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Dynavax Technologies Corporation
Insmed Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Insmed Incorporated and Evotec SE
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Axsome Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Arrowhead Pharmaceuticals, Inc.